Home › Trial NCT00878436
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
- Trial IDNCT00878436
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorNYU Langone Health
- Enrollment52
- Start date2009-06
- ConditionsProstate Cancer · Prostatic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.